Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2024 Deloitte Technology Fast 500 List
Insider Sale: Director at $CPRX (CPRX) Sells 72,500 Shares
Catalyst Pharmaceuticals(CPRX.US) Director Sells US$3.63 Million in Common Stock
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
Stephens Initiates Catalyst Pharmaceuticals(CPRX.US) With Buy Rating, Announces Target Price $35
Stephens & Co. Initiates Coverage On Catalyst Pharmaceuticals With Overweight Rating, Announces Price Target of $35
